Beyond Traditional Hypogonadism: Distinctive Mechanisms and Clinical Implications in Subclinical Functional Hypogonadism (SFH) with Integrative Strategies for Hormonal Homeostasis

Subclinical Functional Hypogonadism (SFH) represents a novel and multifactorial condition that transcends traditional definitions of hypogonadism, characterized by normal or slightly altered testosterone levels but impaired hormonal activity at the tissue level. The physiological response to stress, essential for human survival, has evolved from acute and episodic mechanisms in the past to a chronic and prolonged nature typical of modern society. Studies on Peruvian mummies (Journal of Archaeological Science) show the presence of cortisol, suggesting that stress also existed in primitive humans (Mayer & Rosen, 1975). However, the stress experienced by modern humans is significantly different, arising from factors such as technological overload, work pressures, and disrupted circadian rhythms, further exacerbated by metabolic imbalances and environmental pollutants. These contemporary triggers lead to persistent activation of the HPA axis, resulting in elevated cortisol levels and altered SHBG dynamics, which suppress testosterone bioavailability and disrupt hormonal homeostasis. Unlike classic hypogonadism, SFH often presents sub clinically, with mild or nonspecific symptoms such as reduced libido, fatigue, and increased body fat, alongside systemic impacts on metabolism, mood, and cognitive function. The article distinguishes SFH from stress-related hypogonadism and age-related hormonal decline (Late-Onset Hypogonadism - LOH), emphasizing its unique physiological mechanisms and clinical implications. It also explores integrative strategies, including hormonal therapies, bioneurofeedback, and interventions targeting circadian rhythms, tailored to gender differences, to restore endocrine balance and mitigate the systemic consequences of SFH. This framework highlights the importance of early recognition, precise diagnostic criteria, and personalized approaches to improve hormonal health and overall psycho-physical well-being.

Authors

Publication Details

Journal
International Journal of Psychiatry
Published
2024-12-13
DOI
https://doi.org/10.33140/ijp.09.04.06
Primary Topic
Stress Responses and Cortisol
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond Traditional Hypogonadism: Distinctive Mechanisms and Clinical Implications in Subclinical Functional Hypogonadism (SFH) with Integrative Strategies for Hormonal Homeostasis

Claudio Lombardo
International Journal of Psychiatry
Stress Responses and Cortisol
article

Beyond Traditional Hypogonadism: Distinctive Mechanisms and Clinical Implications in Subclinical Functional Hypogonadism (SFH) with Integrative Strategies for Hormonal Homeostasis

Claudio Lombardo
article en

Abstract

Subclinical Functional Hypogonadism (SFH) represents a novel and multifactorial condition that transcends traditional definitions of hypogonadism, characterized by normal or slightly altered testosterone levels but impaired hormonal activity at the tissue level. The physiological response to stress, essential for human survival, has evolved from acute and episodic mechanisms in the past to a chronic and prolonged nature typical of modern society. Studies on Peruvian mummies (Journal of Archaeological Science) show the presence of cortisol, suggesting that stress also existed in primitive humans (Mayer & Rosen, 1975). However, the stress experienced by modern humans is significantly different, arising from factors such as technological overload, work pressures, and disrupted circadian rhythms, further exacerbated by metabolic imbalances and environmental pollutants. These contemporary triggers lead to persistent activation of the HPA axis, resulting in elevated cortisol levels and altered SHBG dynamics, which suppress testosterone bioavailability and disrupt hormonal homeostasis. Unlike classic hypogonadism, SFH often presents sub clinically, with mild or nonspecific symptoms such as reduced libido, fatigue, and increased body fat, alongside systemic impacts on metabolism, mood, and cognitive function. The article distinguishes SFH from stress-related hypogonadism and age-related hormonal decline (Late-Onset Hypogonadism - LOH), emphasizing its unique physiological mechanisms and clinical implications. It also explores integrative strategies, including hormonal therapies, bioneurofeedback, and interventions targeting circadian rhythms, tailored to gender differences, to restore endocrine balance and mitigate the systemic consequences of SFH. This framework highlights the importance of early recognition, precise diagnostic criteria, and personalized approaches to improve hormonal health and overall psycho-physical well-being.

International Journal of PsychiatryVol. 9(4)
Openalex Percentile: Top 75%
Stress Responses and Cortisol
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Beyond Traditional Hypogonadism: Distinctive Mechanisms and Clinical Implications in Subclinical Functional Hypogonadism (SFH) with Integrative Strategies for Hormonal Homeostasis — Claudio Lombardo · International Journal of Psychiatry (2024) | TGRS Research Map | TGRS